Underfunding our own cleverness has a price
We’re sorry, this service is currently unavailable. Please try again later.
Dismiss
April 14, 2021 — 12.01am
Normal text size
The Age, email letters@theage.com.au. Please include your home address and telephone number.
VACCINE
Underfunding our own cleverness has a price
As a veteran observer of the ups and downs of federal commitment to funding worthy research, it seems that Australia was in a strong position to develop a vaccine that would have been sought after by the rest of the world. The consequences of the delays in vaccine rollout directly affect our ability to competitively bounce back after COVID-19 and prompts the question: what can we learn from the situation?